Sodium aurothiomalate

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Parenteral gold preparation (gold content 46%).

Half-lifeThis section has been translated automatically.

> 600 h

IndicationThis section has been translated automatically.

Dosage and method of useThis section has been translated automatically.

  • Adults: Initial (saturation): Application 2 times/week.
    • 1st to 3rd injection: 10 mg i.m. each
    • 4th to 6th injection: 20 mg i.m. each
    • From the 7th injection (maintenance phase): 2 times/week max. 50 mg i.m. each or 100 mg i.m. once/week.

Remember! Injection deep intragluteal! Effect starts after 4 weeks at the earliest. Maximum total dose 1.6 g!

  • Children:
    • Saturation phase: 0,2-1,0 mg/kg bw/week i.m.
    • Maintenance phase: 1-2 times/month 1 mg/kg bw i.m.

PreparationsThis section has been translated automatically.

Tauredon

Authors

Last updated on: 29.10.2020